[HTML][HTML] Deregulation of HLA-I in cancer and its central importance for immunotherapy

A Hazini, K Fisher, L Seymour - Journal for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
It is now well accepted that many tumors undergo a process of clonal selection which means
that tumor antigens arising at various stages of tumor progression are likely to be …

Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma

P Chai, R Jia, Y Li, C Zhou, X Gu, L Yang, H Shi… - Progress in retinal and …, 2022 - Elsevier
Uveal melanoma (UM) and retinoblastoma (RB), which cause blindness and even death,
are the most frequently observed primary intraocular malignancies in adults and children …

Uveal melanoma: Progress in molecular biology and therapeutics

Y Li, J Shi, J Yang, S Ge, J Zhang… - … advances in medical …, 2020 - journals.sagepub.com
Uveal melanoma (UM) is the most common intraocular malignancy in adults. So far, no
systemic therapy or standard treatment exists to reduce the risk of metastasis and improve …

[HTML][HTML] Genetic landscape and emerging therapies in uveal melanoma

RS Seedor, M Orloff, T Sato - Cancers, 2021 - mdpi.com
Simple Summary Uveal melanoma is the most common primary intraocular malignancy in
adults. Unfortunately, metastasis develops in up to 50% of cases and outcomes are poor for …

[HTML][HTML] How to make immunotherapy an effective therapeutic choice for uveal melanoma

M Marseglia, A Amaro, N Solari, R Gangemi, E Croce… - Cancers, 2021 - mdpi.com
Simple Summary Despite improvements in the early identification and successful control of
primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal …

Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors

NK Sedky, AA Hamdan, S Emad, AL Allam… - Clinical and …, 2022 - Springer
Solid tumors including skin, lung, breast, colon, and prostate cancers comprise the most
diagnosed cancers worldwide. Treatment of such cancers is still challenging specially in the …

Clinical trials in metastatic uveal melanoma: Immunotherapy

M Orloff - Ocular Oncology and Pathology, 2021 - karger.com
Background: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor
prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors …

Novel approaches to the systemic management of uveal melanoma

S Khan, RD Carvajal - Current Oncology Reports, 2020 - Springer
Abstract Purpose of Review Uveal melanoma is a distinct subtype of melanoma
characterized by a unique biology and divergent response to immune therapies. In this …

[HTML][HTML] Targeted Therapy in Ophthalmic Oncology: The Current Status

M Sen, H Demirci, SG Honavar - Asia-Pacific Journal of Ophthalmology, 2024 - Elsevier
There have been rapid advancements in the field of ocular oncology for the diagnosis and
management of intraocular, adnexal, and orbital tumors. Targeted therapy is in the forefront …

[HTML][HTML] Thinking small: Small molecules as potential synergistic adjuncts to checkpoint inhibition in melanoma

AC Chacon, AD Melucci, SS Qin, PA Prieto - International Journal of …, 2021 - mdpi.com
Metastatic melanoma remains the deadliest form of skin cancer. Immune checkpoint
inhibition (ICI) immunotherapy has defined a new age in melanoma treatment, but …